×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

QuidelOrtho Corporation. (QDEL) NASDAQ

$73.04 1.17 (1.63%)

Market Cap: $4.88B

As of 09/29/23 04:00 PM EDT. Market closed.

(QDEL)

QuidelOrtho Corporation. (QDEL)
NASDAQ

$73.04
1.17 (1.63%)

Market Cap: $4.88B

As of 09/29/23 04:00 PM EDT. Market closed.

QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold ... read more

QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO
Douglas C. Bryant
Full Time Employees
1,500
CEO Compensation (Base)
$589,438
CEO Compensation (Total)
$3.42M
URL
Address
.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO
Douglas C. Bryant
Full Time Employees
1,500
CEO Compensation (Base)
$589,438
CEO Compensation (Total)
$3.42M
Address
.
PRICE CHART FOR QUIDELORTHO CORPORATION
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$72.43
Previous Close
$71.87
Days Range
$72.03 - $73.57
52 week range
$66.88 - $102
Volume
466,306
Avg. Volume (30 days)
563,362
Market Cap
$4.88B
Dividend Yield
-
P/E
4.85
Shares Outstanding
66,790,619
Open
$72.43
Previous Close
$71.87
Days Range
$72.03 - $73.57
52 week range
$66.88 - $102
Volume
466,306
Avg. Volume (30 days)
563,362
Market Cap
$4.88B
Dividend Yield
-
P/E
4.85
Shares Outstanding
66,790,619
FINANCIAL STATEMENTS FOR QUIDELORTHO CORPORATION
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR QUIDELORTHO CORPORATION
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Bujarski Robert JosephEVP & COOSep 14, 2023 Option Exercise$76.3715611,91436,270Sep 18, 2023, 05:45 PM
BRYANT DOUGLAS CPresident & CEOAug 24, 2023 Option Exercise$78.3372556,789535,570Aug 28, 2023, 04:05 PM
Kroll WernerSVP, Research & DevelopmentJul 28, 2023 Option Exercise$87.1254947,82929,639Aug 01, 2023, 04:05 PM
Iskra Michael S.EVP & CCOJun 01, 2023 Option Exercise$85.651,839157,51010,907Jun 05, 2023, 06:14 PM
Busky Joseph MChief Financial OfficerJun 01, 2023 Option Exercise$85.651,637140,2093,946Jun 05, 2023, 06:14 PM
Brandy LouiseSVP, Chief Information OfficerJun 01, 2023 Option Exercise$85.6521518,415878Jun 05, 2023, 06:14 PM
Smith Christopher MDirectorMay 27, 2023 Option Exercise$85.541,225104,78733,329May 31, 2023, 04:05 PM
Hodges Michelle A.SVP, General CounselMay 25, 2023 Option Exercise$84.7214612,3694,575May 30, 2023, 04:05 PM
BRYANT DOUGLAS CPresident & CEOFeb 23, 2023 Option Exercise$88.717,527667,720534,543Feb 27, 2023, 04:15 PM
BUECHLER KENNETH FDirectorFeb 17, 2023 Option Exercise$23.708,081191,52078,369Feb 22, 2023, 04:15 PM
BUECHLER KENNETH FDirectorFeb 17, 2023 Sale$90.268,081729,36670,288Feb 22, 2023, 04:15 PM
Kroll WernerSVP, Research & DevelopmentFeb 11, 2023 Option Exercise$86.501,705147,48328,255Feb 14, 2023, 04:46 PM
Bujarski Robert JosephEVP & COOFeb 11, 2023 Option Exercise$86.501,815156,99836,112Feb 14, 2023, 04:45 PM
BRYANT DOUGLAS CPresident & CEOFeb 11, 2023 Option Exercise$86.504,540392,710526,890Feb 14, 2023, 04:44 PM
Bujarski Robert JosephEVP & COOFeb 04, 2023 Option Exercise$89.701,905170,87834,354Feb 07, 2023, 04:15 PM
Bujarski Robert JosephEVP & COOFeb 03, 2023 Option Exercise$89.7087378,30832,636Feb 07, 2023, 04:15 PM
BRYANT DOUGLAS CPresident & CEOFeb 04, 2023 Option Exercise$89.709,282832,595521,929Feb 07, 2023, 04:15 PM
BRYANT DOUGLAS CPresident & CEOFeb 03, 2023 Option Exercise$89.701,882168,815512,491Feb 07, 2023, 04:15 PM
Kroll WernerSVP, Research & DevelopmentFeb 04, 2023 Option Exercise$89.704,064364,54126,394Feb 07, 2023, 04:15 PM
Kroll WernerSVP, Research & DevelopmentJan 31, 2023 Option Exercise$85.611,840157,52221,553Feb 02, 2023, 05:57 PM
Kroll WernerSVP, Research & DevelopmentFeb 01, 2023 Option Exercise$88.5165157,62022,265Feb 02, 2023, 05:57 PM
Hodges Michelle A.SVP, General CounselFeb 01, 2023 Option Exercise$88.5116214,3394,301Feb 02, 2023, 05:57 PM
Hodges Michelle A.SVP, General CounselJan 31, 2023 Option Exercise$85.6164355,0473,990Feb 02, 2023, 05:57 PM
Bujarski Robert JosephEVP & COOFeb 01, 2023 Option Exercise$88.5146340,98031,849Feb 02, 2023, 05:56 PM
Bujarski Robert JosephEVP & COOJan 31, 2023 Option Exercise$85.611,771151,61531,433Feb 02, 2023, 05:56 PM
BRYANT DOUGLAS CPresident & CEOJan 31, 2023 Option Exercise$85.613,406291,588510,016Feb 02, 2023, 05:55 PM
BRYANT DOUGLAS CPresident & CEOFeb 01, 2023 Option Exercise$88.5155348,946510,578Feb 02, 2023, 05:55 PM
Hodges Michelle A.SVP, General CounselDec 01, 2022 Option Exercise$93.6511911,1443,024Dec 05, 2022, 04:05 PM
Bujarski Robert JosephPresident & COONov 18, 2022 Option Exercise$88.4054448,09029,985Nov 21, 2022, 04:26 PM
Hodges Michelle A.SVP, General CounselNov 08, 2022 Option Exercise$87.691,969172,6622,905Nov 10, 2022, 04:05 PM
Bujarski Robert JosephPresident & COOOct 15, 2022 Option Exercise$76.2920515,63929,496Oct 17, 2022, 04:35 PM
Hodges Michelle A.SVP, General CounselOct 15, 2022 Option Exercise$76.2919314,724904Oct 17, 2022, 04:33 PM
Bujarski Robert JosephPresident & COOSep 14, 2022 Option Exercise$83.2516513,73629,312Sep 16, 2022, 04:05 PM
BRYANT DOUGLAS CChairman & CEOAug 24, 2022 Option Exercise$85.8072462,119506,662Aug 26, 2022, 04:05 PM
Kroll WernerSVP, Research & DevelopmentJul 28, 2022 Option Exercise$102.3758159,47719,846Aug 01, 2022, 07:16 PM
Kroll WernerSVP, Research & DevelopmentJul 01, 2022 Option Exercise$97.1148647,19519,257Jul 06, 2022, 05:52 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Bujarski Robert JosephEVP & COO09/14/202311,914
BRYANT DOUGLAS CPresident & CEO08/24/202356,789
Kroll WernerSVP, Research & Development07/28/202347,829
Iskra Michael S.EVP & CCO06/01/2023157,510
Busky Joseph MChief Financial Officer06/01/2023140,209
Brandy LouiseSVP, Chief Information Officer06/01/202318,415
Smith Christopher MDirector05/27/2023104,787
Hodges Michelle A.SVP, General Counsel05/25/202312,369
BRYANT DOUGLAS CPresident & CEO02/23/2023667,720
BUECHLER KENNETH FDirector02/17/2023191,520
BUECHLER KENNETH FDirector02/17/2023729,366
Kroll WernerSVP, Research & Development02/11/2023147,483
Bujarski Robert JosephEVP & COO02/11/2023156,998
BRYANT DOUGLAS CPresident & CEO02/11/2023392,710
Bujarski Robert JosephEVP & COO02/04/2023170,878
Bujarski Robert JosephEVP & COO02/03/202378,308
BRYANT DOUGLAS CPresident & CEO02/04/2023832,595
BRYANT DOUGLAS CPresident & CEO02/03/2023168,815
Kroll WernerSVP, Research & Development02/04/2023364,541
Kroll WernerSVP, Research & Development01/31/2023157,522
Kroll WernerSVP, Research & Development02/01/202357,620
Hodges Michelle A.SVP, General Counsel02/01/202314,339
Hodges Michelle A.SVP, General Counsel01/31/202355,047
Bujarski Robert JosephEVP & COO02/01/202340,980
Bujarski Robert JosephEVP & COO01/31/2023151,615
BRYANT DOUGLAS CPresident & CEO01/31/2023291,588
BRYANT DOUGLAS CPresident & CEO02/01/202348,946
Hodges Michelle A.SVP, General Counsel12/01/202211,144
Bujarski Robert JosephPresident & COO11/18/202248,090
Hodges Michelle A.SVP, General Counsel11/08/2022172,662
Bujarski Robert JosephPresident & COO10/15/202215,639
Hodges Michelle A.SVP, General Counsel10/15/202214,724
Bujarski Robert JosephPresident & COO09/14/202213,736
BRYANT DOUGLAS CChairman & CEO08/24/202262,119
Kroll WernerSVP, Research & Development07/28/202259,477
Kroll WernerSVP, Research & Development07/01/202247,195
Load More Insider Transactions
FUNDS WITH A POSITION IN QUIDELORTHO CORPORATION
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.5,000,2810.01%0.03%Other
GEODE CAPITAL MANAGEMENT, LLC848,8970.00827%6.92%Other
RENAISSANCE TECHNOLOGIES LLC542,7550.06%4.84%Other
AQR CAPITAL MANAGEMENT LLC308,4800.05%-17.52%Other
GABELLI FUNDS LLC126,7540.08%No changeEvent Driven, Growth, Activists
FIRST EAGLE INVESTMENT MANAGEMENT, LLC115,9060.02%48.04%Value
BRIDGEWATER ASSOCIATES, LP54,2770.03%-9.6%Other
GOTHAM ASSET MANAGEMENT, LLC39,1470.07%70.72%Other
ROYCE & ASSOCIATES LP10,0000.00804%-89.62%Value
BALYASNY ASSET MANAGEMENT L.P.8,1140.00148%NewEvent Driven
HOLOCENE ADVISORS, LP3,5970.00127%-69.18%Growth At A Reasonable Price
MAVERICK CAPITAL LTD2,7600.00487%-20.12%Growth At A Reasonable Price, Growth
CHANGE IN SHARES OUTSTANDING FOR QUIDELORTHO CORPORATION
STOCK BUYBACKS FOR QUIDELORTHO CORPORATION
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
07/02/2023
04/02/2023
-0.45%
1Q
07/02/2023
01/01/2023
-0.30%
2Q
07/02/2023
10/02/2022
-1.04%
3Q
07/02/2023
07/03/2022
26.28%
4Q
Load More

Period of Report: 07/02/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
04/02/2023
-0.45%
1Q
01/01/2023
-0.30%
2Q
10/02/2022
-1.04%
3Q
07/03/2022
26.28%
4Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR QUIDELORTHO CORPORATION
LOADING...